A molecule is not a medicine
until someone can make it.
Panacea Biopharmatec is the sister company of Panacea Biochem devoted to the physical craft of the dosage form. The active pharmaceutical ingredient is only the beginning: someone must teach it to flow, to bind, to compress, to carry a coat, to release on cue. That craft — formulation, granulation, tablet pressing, film coating, excipient science — is our house's whole subject.
What this house works on
Between the pure API in its drum and the tablet in a patient's hand stands a chain of unit operations, each with its own physics and its own failure modes. Panacea Biopharmatec's work is that entire chain — no step of it outsourced to luck.
Formulation science
A formulation is a negotiation between the API and everything that must surround it. Solubility, polymorph, particle size, stability — the molecule sets the constraints, and the formulation answers them. The first question is never "which excipient" but "what does this API refuse to tolerate".
Direct compression vs granulation
If a blend flows freely and mixes evenly, direct compression is the honest route: fewest steps, least stress on the API. When it does not, the powder is first engineered — wet granulation with a binder liquid and drying, or dry granulation by roller compaction when moisture and heat are unwelcome. The powder chooses the route.
Tablet pressing
Inside a rotary press, punches and dies turn a metered volume of powder into a compact in a fraction of a second. Tooling geometry, compression force and dwell time set the tablet's strength — and the trade-off is real: harder tablets resist chipping but may disintegrate too slowly. Friability, hardness and disintegration are tuned together, never separately.
Film coating
A polymer film tens of microns thick, sprayed onto tumbling cores. Cosmetic coats give gloss, colour and identity; functional coats mask taste, shield against moisture and light, or — as enteric barriers — carry the tablet untouched through the stomach to release in the intestine. We keep the two categories honest: a coat that only decorates is never sold as protection.
Excipient science
Fillers for bulk, binders for strength, disintegrants for break-up, lubricants so the press lets go, glidants so the powder flows. Excipients are called inactive, but nothing that decides whether a tablet exists at all is truly inert. Their grades, particle sizes and interactions are engineering parameters, not afterthoughts.
Content uniformity & dissolution
Two questions close the loop. Does every tablet carry the same dose — content uniformity, fought against segregation at every transfer step? And does the tablet release its API at the rate the therapy assumes — dissolution, the rehearsal of what the body will ask? A batch answers both, or it does not ship.
The press is an argument with physics
Every tablet is a small powder-compaction experiment run at industrial tempo. Air must escape the die before the punches close; particles must deform and bond in milliseconds; the compact must survive ejection without capping or lamination. Get the balance wrong and the press tells you immediately — in chipped edges, in split crowns, in weights that drift. Get it right and the machine settles into the oldest rhythm in solid dose manufacturing: fill, compress, eject. The full lineage — Brockedon, Korsch, Fette, Manesty, Wurster — is told on The Craft page.
Two sisters, one standard
Panacea Biochem (panaceabiochem.co.uk) is the molecular sister: peptides, lyophilization and formulation research — the LyoLevit levitated freeze-drying platform and the peptide-preservation line. Panacea Biopharmatec is the manufacturing-technology sister: everything the API meets after it exists — blending, granulation, compression, coating, release. One designs the substance; the other teaches the substance to become a dosage form. Both answer to the same founder, biochemist and AAC designer Bogdan Dicoias, and to the same rule: state precisely what is known, and nothing more.
Technology house · no products offered for sale on this site"The molecule is the argument; the tablet is the verdict. Formulation is where a brilliant API learns manners — how to flow, how to hold together, and how to let go at exactly the right moment."
Bogdan Dicoias — Biochemist · AAC Designer · founder of Panacea Biopharmatec
Frequently asked questions
What is Panacea Biopharmatec?
The sister company of Panacea Biochem devoted to API manufacturing technology: the formulation science and unit operations that turn an active pharmaceutical ingredient into a real, manufacturable dosage form.
How is it different from Panacea Biochem?
Panacea Biochem works on molecules — peptides, lyophilization, formulation research. Panacea Biopharmatec works on the physical craft of the dosage form: powder behaviour, compression, coating and release.
Direct compression or granulation?
The powder decides. Well-behaved blends go straight to the press; difficult blends are granulated first — wet, or dry by roller compaction when solvent and heat are unwelcome.
Why film-coat a tablet?
Cosmetic coats give gloss and identity; functional coats mask taste, protect the API, or form an enteric barrier that postpones release until the intestine. More answers on the Questions page.
Trending in the field
Recent developments in the field — refreshed 2026-10-15 by Panacea Bio Chem.
- In-line laser triangulation-based 3D profiling for real-time tablet monitoring in a rotary tablet press — PubMed, 2026 Oct 9
- Mechanochemistry via Bead-milling: an Emerging Tool Towards Greener and Scalable Organic Synthesis — PubMed, 2026 Sep 30
- Effect of tablet press residence time distribution on material traceability in a Direct Compression Mini-Batch Blending process - Part 2: comparison of different feed frame designs, a DEM study — PubMed, 2026 Sep 5
- Process-dependent N-nitroso-ketamine formation during ketamine active pharmaceutical ingredient manufacturing: part I impact of process design, solvent selection, and activated carbon — PubMed, 2026 Sep 5


























